Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Science Signaling|October 19, 2017
The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1Daniel N Meijles, Sanghamitra Sahoo, Imad Al Ghouleh, et al.Diabetologia|May 7, 2026
Human pancreatic ductal cells from non-diabetic donors function as non-professional antigen-presenting cells upon inflammatory cytokine exposureNeslihan Erdem, David Arribas-Layton, Heather N Zook, et al.Plos One|December 22, 2022
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, et al.Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.Results in Immunology|December 28, 2013
A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritisPedro C Rodriguez, Roberto Torres-Moya, Gil Reyes, et al.Transplantation Direct|March 25, 2026
Donation After Circulatory Death Islets are Comparable to Standard-of-Care Donation After Brain Death Islets: Analysis of 801 Consecutive Human Islet IsolationsMeirigeng Qi, Keiko Omori, Christopher Orr, et al.Pulmonary Circulation|July 10, 2014
Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertensionNatasha M Rogers, Mingyi Yao, John Sembrat, et al.Journal of the American Academy of Dermatology|April 8, 2014
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III studyD S Krupashankar, Sunil Dogra, Mahendra Kura, et al.The Lancet. Haematology|November 21, 2017
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trialManuela Aguilar-Guisado, Ildefonso Espigado, Almudena Martín-Peña, et al.Cardiovascular Research|October 16, 2016
TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunctionNatasha M Rogers, Maryam Sharifi-Sanjani, Mingyi Yao, et al.Pageof 12